Dolly expert is to clone embryos
By BBC News,
BBC News
| 02. 08. 2005
The creator of Dolly the sheep has been granted a licence to clone human embryos for medical research.
Professor Ian Wilmut and Kings College London scientists will clone early stage embryos to study motor neurone disease (MND).
This is the second time the Human Fertilisation and Embryology Authority has given such permission.
Critics maintain that testing human embryos is immoral. Others question the potential benefits of the work.
Professor Wilmut said it will mean MND can be studied in unprecedented detail.
Therapeutic cloning for research has been legal in the UK since 2001 and it would be only the second time the authority has given consent.
The professor's team was the first to apply for a therapeutic cloning licence in the country.
Up until now, scientists have wanted to create cloned embryos to see if they can be grown into tissues to repair damaged body parts.
But Professor Wilmut's proposal is different as he does not plan to grow healthy replacement tissue.
Instead he aims to deliberately clone embryos that have MND from patients who have the condition.
Professor Wilmut...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...